Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2015 Volume 11 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2015 Volume 11 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes

  • Authors:
    • Feng Lv
    • Yang Yu
    • Guihua Wang
    • Junbo Hu
    • Bin Zhang
    • Wei You
    • Jing Wang
  • View Affiliations / Copyright

    Affiliations: Department of Breast Surgery, Henan Provincial People's Hospital, The People's Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China, Department of Molecular Medical Center, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hebei 430030, P.R. China, Department of Immunology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hebei 430030, P.R. China
  • Pages: 3753-3759
    |
    Published online on: January 12, 2015
       https://doi.org/10.3892/mmr.2015.3184
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

To understand the association between the cytokine network and psoriasis, the present study cultured human keratinocytes (HaCaT cells) and investigated the effects of the phosphatidylinositol‑3‑kinase (PI3K) p55 regulatory subunit (p55PIK), and its N‑terminal 24 amino acids (N24) on the regulation of endotoxin (LPS)‑induced cytokine secretion. The results of the enzyme‑linked immunosorbent assay and reverse transcription quantitative polymerase chain reaction revealed an increased release of the inflammatory cytokines, tumor necrosis factor (TNF)‑α, interleukin (IL)‑6 and IL‑8 in the HaCaT cells following LPS stimulation. Transfection with the adenovirus (AD)‑N24‑green fluorescent protein (GFP) suppressed the release of these cytokines, whereas AD‑p55PIK‑GFP increased their release. Immunocytochemistry detected a low level of nuclear factor (NF)‑κB p65 staining in quiescent HaCaT cells, which was localized primarily in the cytoplasm. LPS stimulation induced the translocation of NF‑κB p65 protein into the nucleus and intense staining suggested increased expression. Transfection with AD‑N24‑GFP reduced the expression of NF‑κB p65 in the nucleus. Western blot analysis demonstrated that AD‑N24‑GFP downregulated the expression levels of the Toll‑like receptor (TLR)2/TLR4/myeloid differentiation factor 88 (MyD88) pathway components in the HaCaT cells, without affecting the PI3K/Akt signaling pathway. Transfection with AD‑p55PIK‑GFP resulted in an increased expression level of MyD88 protein and phosphorylated Akt. Co‑transfection with AD‑N24‑GFP and AD‑p55PIK‑GFP did not significantly alter the levels of phosphorylated extracellular‑signal‑regulated kinases 1/2, c‑Jun N‑terminal kinases or p38, indicating that AD‑N24‑GFP and AD‑p55PIK‑GFP did not affect the mitogen‑activated protein kinase signaling pathway. In conclusion, AD‑N24‑GFP effectively inhibited the LPS‑induced expression levels of TNF‑α, IL‑6 and IL‑8. The elevated expression of p55PIK synergized with LPS and promoted the release of inflammatory cytokines. AD‑N24‑GFP and AD‑p55PIK‑GFP affected LPS‑induced inflammatory cytokine release in the HaCaT cells through the TLRs/MyD88 signaling pathways.

Introduction

Autoimmunity is the failure of an organism to recognize its own constituents as self, which causes an immune response against its own cells and tissues. Any disease resulting from this aberrant immune response is termed autoimmune disease (AID) (1). AID is frequently observed clinically and therapy for AID often includes treatment with hormones and immunosuppressants (1). These agents are effective in the short-term, however, long-term use increases the incidence of tumors and uncontrolled infectious diseases due to various side effects (1,2). Therefore, AID is recognized worldwide as a ‘5D’ disease, which comprises discomfort, disability, drug toxicity, dollar loss and death (3).

Psoriasis is a common AID and the primary pathological features include the abnormal proliferation of epidermal cells and infiltration of inflammatory cells. Although the exact pathogenesis of psoriasis has not been fully elucidated, the importance of T cells has been demonstrated in previous studies (4,5). Cytokines within psoriatic lesions, including tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6 and IL-8 (6–8), are subject to complex interactions and regulation, suggesting their importance in the development of this inflammatory disease. Therefore, understanding the interactions involved in the cytokine network has been a major area of focus in the investigation of the pathogenesis of psoriasis (9). In the present study, to further understand the association between the cytokine network and psoriasis, human keratinocytes (HaCaT cells) were cultured in vitro (10,11) to investigate the effects of the N-terminal 24 amino acids (N24) and the expression of the p55 regulatory subunit of phosphatidylinositol 3-kinase (p55PIK) on the regulation of endotoxin (LPS)-induced cytokine secretion.

Materials and methods

Cells and plasmids

The HaCaT cell line was purchased from the American Type Culture Collection (Manassas, VA, USA) and was subcultured in the laboratory and stored at −80°C. The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco Life Technologies, Carlsbad, CA, USA) containing 15% newborn calf serum (Evergreen, Hangzhou, China) and 100 μg/ml penicillin and streptomycin (Evergreen) and incubated at 37°C with 5% CO2. The N24 and p55PIK adenoviruses (Evergreen) were purified and stored in the laboratory as previously described (12).

Reagents

Trypsin was purchased from Gibco Life Technologies, LPS (<0.008% protein from E. coli K235) was purchased from Sigma-Aldrich (St. Louis, MO, USA) and the TNF-α and IL enzyme-linked immunosorbent assay (ELISA) kits were purchased from Westang Biotechnology (Shanghai, China).

Cryopreservation of the HaCaT cells and in vitro culture

The HaCaT cells stored in cryovials (Biyuntian Health Care Products Co., Hangzhou, China) were removed from the −80°C freezer and rapidly thawed by submersing the cryovial in a 37°C water bath. The cryovial tubes were opened in a laminar flow hood and the cell suspension was transferred into centrifuge tubes and centrifuged (Beckman Coulter, Brea, CA, USA) at a low speed (100 × g for 5 min). The supernatant was discarded and the cell pellet was gently resuspended in DMEM containing 15% newborn calf serum and 100 μg/ml penicillin and streptomycin and transferred into a culture flask (Biyutian Health Care Products Co.). The cells were cultured in a 37°C thermostatic incubator with 5% CO2 and the medium was replaced every 2–3 days until a confluent monolayer had formed. The cells were washed three times with D-Hanks solution (Biyutian Health Care Products Co.) prior to the addition of 1 ml of 0.25% trypsin and incubated for 10 min at 37°C in a 5% CO2 atmosphere. DMEM (10 ml) was added to terminate the digestion upon detachment of the adherent cells from the bottom of the flask. The cells were gently dissociated by pipetting up and down into a single cell suspension and 1×104 cells were transferred into a new flask. The medium was replaced every 2–3 days and the cells were passaged every ~6 days. Viable cells with a healthy morphology were used for experiments.

ELISA detection of inflammatory cytokine secretion by HaCaT cells

The following groups were evaluated: Blank control, LPS-stimulation, adenovirus (AD) expressing-green fluorescent protein (GFP), AD-N24-GFP, AD-p55PIK-GFP, AD-GFP+LPS, AD-N24-GFP+LPS and AD-p55PIK-GFP+LPS. Viable cells were seeded into six-well plates, incubated at 37°C and transduced with AD-GFP, AD-N24-GFP or AD-p55PIK-GFP viruses until the cells reached 70% confluence. The transduction efficiency multiplicity of infection value was set to 100 and the cells were further cultured for 24 h at 37°C. The cells were stimulated using LPS (10 μl) at a final concentration of 100 ng/ml for 4 h, and the culture supernatants were collected and stored at −80°C until use. The assays were performed within two weeks.

Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to assess the effects of AD-GFP, AD-N24-GFP and AD-p55PIK-GFP on the mRNA expression levels of TNF-α, IL-6 and IL-8 mRNA in LPS-stimulated HaCaT cells

The primers for RT-qPCR were synthesized by Invitrogen Biotechnology Co., Ltd. (Shanghai, China), based on the receptor mRNA template from the GenBank nucleotide sequence database (TNF-α, NM000594.2, 8 July 2012; IL-6, NM000600.3, 11 May 2014 and IL-8 NM000584.2, 6 February 2011). The primers were purified using a PAGE method (Invitrogen Biotechnology Co., Ltd) and the following primer sequences were used: TNF-α, forward 5′-CGAGTGACAAGCCTGTAGCC-3′ and reverse 5′-TGAAGAGGACCTGGGAGTAGAT-3′; IL-6, forward 5′-AGCCACTCACCTCTTCAGAACG-3′ and reverse 5′-TGCCTCTTTGCTGCTTTCACA-3′; IL-8, forward 5′-CTCCAAACCTTTCCACCCC-3′ and reverse 5′-TCCACAACCCTCTGCACCC-3′ and GAPDH, forward 5′-GATTTGGTCGTATTGGGCG-3′ and reverse 5′-CCTGGAAGATGGTGATGGG-3′. To ensure the consistency of the RNA samples, GAPDH was used as an internal control. The total RNA from the HaCaT cells was extracted using TRIzol Total RNA Isolation reagent (Tiangen Biotech Co., Beijing, China) according to the manufacturer’s instructions. RT-qPCR was performed based on the features of the primers and the conditions for the PCR reactions were determined from pilot experiments using a SYBR Green mix (Tiangen Biotech Co., Beijing, China), according to the manufacturer’s instructions. The PCR results were analyzed for the target gene expression by the 2−ΔΔCT method. In this formula, the cycle threshold (CT) is defined as the number of cycles required for the fluorescent signal to cross the threshold and exceed the background level. ΔΔCT = (experimental group CT target gene - CT housekeeping gene) - (control group Ct target gene - Ct housekeeping gene). Therefore, 2−ΔΔCT represents the fold-change of the target gene in the experimental group relative to the control group. This method directly calculates the levels of the target gene expression relative to those of the housekeeping gene.

Immunohistochemistry assay for nuclear factor (NF)-κB activity

Viable cells were cultured on cover glasses and subjected to immunohistochemical staining with a Diaminobenzidine Histochemistry kit (Biyuntian Health Care Products Co.) to detect NF-κB p65-positive cells. NF-κB p65-positive cells were detected based on brown staining in the cell nuclei. To calculate the numbers of positive cells, five regions from each cover glass (Tiangen Biotech Co., Beijing, China) were randomly selected under a magnification of ×200 (Leica DMIL 090-135.002; Leica Microsystems GmbH, Wetzlar, Germany). The positive cell ratio was calculated by comparing the number of positively stained cells with the total number of cells. Positive cell ratio (%) = number of positive cells/number of total cells × 100%.

Western blot analysis to detect the protein expression levels of the Toll-like receptor (TLR)2/TLR4/myeloid differentiation factor 88 (MyD88)/PI3K/Akt and mitogen-activated protein kinase (MAPK) signaling pathways and of the IκB-α NF-κB inhibitor

The expression levels of these proteins were monitored in the HaCaT cells expressing either AD-N24-GFP or AD-p55PIK-GFP at different time-points following LPS stimulation to confirm the timing of the peak expression. The proteins were extracted, according to the instructions provided by Santa Cruz Biotechnology, Inc. (Dallas, TX, USA) and bovine serum albumin Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used as the standard. The cells from all the groups were lysed in cold NP-40 protein lysis buffer [50 mM Tris (pH 7.4), 150 mM NaCI, 0.5% NP-40, 20% glycerol with 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, leupeptin and pepstatin (10 g/mI each) and 100 pg/mI aprotinin] for 20 min. Lysates were clarified by centrifugation at 10,000 × g and 4°C for 20 min. The standard curve for protein concentration was calculated using a Bio-Rad Protein Assay kit (Bio-Rad Laboratories, Inc.) according to the manufacturer’s instructions. The absorbance values were detected at 595 nm on a spectrophotometer (NanoDrop1000; Thermo Fisher Scientific, Wilmington, DE, USA) and the target protein concentration was calculated based on the standard curve. The total protein (20 μg) was loaded onto a 12% polyacrylamide gel for electrophoresis and then transferred onto a polyvinylidene difluoride membrane at 100 V for 1 h. Primary antibodies (Santa Cruz Biotechnology, Inc.) were diluted 1:1,000 in PBS and added to the membrane following blocking with 5% skim milk. GAPDH was used as a loading control. The antibodies used were as follows: rabbit polyclonal immunoglobulin G (IgG) anti-NFκB p65 (C-20; sc-372); rabbit polyclonal IgG anti-TLR2 (H-175; sc-10739); rabbit polyclonal IgG anti-TLR4 (H-80; sc-10741); rabbit polyclonal IgG anti-MyD88 (HFL-296; sc-11356); rabbit polyclonal IgG anti-Akt1/2/3 (H-136; sc-8312); rabbit polyclonal IgG anti-p-Akt1/2/3 (Ser473; sc-7985)-R; rabbit polyclonal IgG anti-ERK 1/2 (H-72; sc-292838); goat polyclonal IgG p-ERK 1/2 (Thr202/Tyr204; sc-16982); rabbit IgG JNK (FL; sc-571); rabbit polyclonal IgG p-JNK (Thr183; sc-135642); rabbit polyclonal IgG GAPDH (FL-335; sc-25778); rabbit polyclonal IgG p38 (H-147; sc-7149) and rabbit polyclonal IgG p-p38 (Tyr182; sc-101759). Horseradish peroxidase-conjugated secondary antibodies (diluted 1:5,000; donkey anti-goat IgG-HRP, sc-2020, and goat anti-rabbit IgG-HRP, sc-2004; Santa Cruz Biotechnology, Inc.) and an enhanced chemiluminescence detection kit (SuperSignal West Femto Maximum Sensitivity Substrate Trial kit; Pierce Biotechnology, Inc., Thermo Fisher Scientific, Rockford, IL, USA) were used to detect the hybridization signal.

Statistical analysis

The statistical significance was assessed using SPSS 11.5 software (SPSS, Inc., Chicago, IL, USA) and the date represent the mean ± standard deviation. Differences between the groups were analyzed using unpaired two-tailed Student’s t-tests. P<0.05 was considered to indicate a statistically significant difference.

Results

Effects of AD-N24-GFP and AD-p55PIK-GFP on LPS-induced inflammatory cytokine release by HaCaT cells

ELISA was used to measure changes in the release of the inflammatory cytokines, IL-6 and IL-8, upon LPS-stimulation following AD-N24-GFP or AD-p55PIK-GFP transfection in the HaCaT cells. IL-6 and IL-8 were detected in quiescent cells (6.44±0.95 and 50.97±13.14 pg/ml, respectively), however, the levels of IL-6 and IL-8 in the culture supernatant increased to different extents following LPS-stimulation for 4 h (88.32±7.43 and 314.57±30.82 pg/ml, respectively). A more marked increase was observed in the expression of IL-8 compared with IL-6, although statistically significant differences were observed for each protein (P<0.05). Upon transfection with AD-N24-GFP, the LPS-induced release of IL-6 and IL-8 by the HaCaT cells decreased to 51.25±4.79 and 174.61±26.02 pg/ml, respectively. These differences were statistically significant (P<0.05). Upon transfection with AD-p55PIK-GFP, the expression levels of IL-6 and IL-8 increased to 120.99±13.74 and 450.28±32.2 pg/ml, respectively. These differences were also statistically significant (P<0.05). The data are shown in Fig. 1.

Figure 1

Enzyme-linked immunosorbent assay results indicating the effect of AD-N24-GFP and AD-p55PIK-GFP on the LPS-stimulated release of the (A) IL-6 and (B) IL-8 inflammatory factors (**P<0.01, compared with the control group; ##P<0.01, compared with the LPS group). LPS, endotoxin; IL, interleukin, GFP, green fluorescent protein, CON, control, N24, N-terminal 24 amino acids; AD, adenovirus. Values are expressed as the mean ± standard error of the mean of three independent experiments.

RT-qPCR to determine the LPS-induced mRNA expression of TNF-α, IL-6 and IL-8 by HaCaT cells prior to and following AD-N24-GFP or AD-p55PIK-GFP transfection

Compared with the unstimulated group, LPS-stimulation led to an almost five-fold increase in the mRNA expression levels of TNF-α, IL-6 and IL-8 following transfection with AD-N24-GFP. This was significantly lower compared with that of the untransfected group in response to LPS-stimulation. The mRNA expression levels of the inflammatory cytokines TNF-α, IL-6 and IL-8 induced by LPS-stimulation were significantly increased upon transfection with AD-p55PIK-GFP, indicating that an increase in the intracellular expression of p55PIK promoted inflammatory cytokine release. The results are shown in Fig. 2.

Figure 2

Reverse transcription quantitative polymerase chain reaction detection of the mRNA expression levels of TNF-α, IL-6 and IL-8 in the HaCaT cells (*P<0.05, compared with the control group; #P<0.05, compared with the LPS group). Ct, cycle threshold; con, control; GFP, green fluorescent protein; LPS, endotoxin; IL, interleukin, N24, N-terminal 24 amino acids; P55PIK, p55 regulatory subunit of phosphatidylinositol 3-kinase; TNF, tumor necrosis factor; HaCaT, human keratinocytes; AD, adenovirus. Values are expressed as the mean ± standard error of the mean of three independent experiments.

Immunocytochemistry to detect the expression of NF-κB

HaCaT cells were cultured on cover glass, fixed and immunocytochemistry was performed. The numbers of LPS-induced NF-κB p65-positive HaCaT cells prior to and following transfection with AD-N24-GFP were counted under a microscope. The quiescent HaCaT cells contained few NF-κB p65-positive cells (3.04±1.13%) compared with the LPS stimulated group, in which LPS almost fully activated NF-κB p65 (87.57± 5.38%). Following transfection with AD-N24-GFP, the number of NF-κB p65-positive HaCaT cells decreased to 54.43±6.54%, which was statistically significant compared with the LPS group (P<0.01). The results are shown in Fig. 3.

Figure 3

Immunocytochemical analysis of the protein expression of nuclear factor-κB p65 in the HaCaT cells treated with LPS and AD-N24. The cells were stained with diaminobenzadine (magnification, ×200). (**P<0.01, compared with the control group; ##P<0.01, compared with the LPS group). CON, control; GFP, green fluorescent protein; LPS, endotoxin; N24, N-terminal 24 amino acids; HaCaT, human keratinocytes; AD, adenovirus.

Protein expression analyses of the TLR signaling pathways in the LPS-simulated HaCaT cells expressing AD-N24-GFP or AD-p55PIK-GFP

The expression levels of the TLR2/TLR4/MyD88/PI3K/Akt signaling pathway proteins were investigated. As shown in Fig. 5, TLR2 and TLR4 were expressed in the HaCaT cells. LPS-stimulation increased the expression levels of TLR2 and TLR4 in the HaCaT cells, with the peak increase observed 4 h and 8 h post-stimulation. These levels remained higher than normal for at least 24 h. The expression of MyD88 gradually increased following LPS-stimulation, peaked at 4 h and then gradually decreased, however remained higher compared with the normal level at 24 h. The phosphorylation of Akt gradually increased (P<0.05) 30 min after LPS-stimulation, peaked at 4 h (P<0.05) and then decreased rapidly and returned to normal levels by 24 h. Transfection with AD-GFP had no affect on the expression of the proteins, whereas transfection with AD-N24-GFP significantly downregulated the protein expression levels of TLR2 and TLR4 following LPS stimulation compared with the LPS-stimulated group. The protein expression of MyD88 also decreased and no change in the expression of phosphorylated Akt was observed, suggesting that the AD-N24-GFP protein downregulated the expression levels of TLR2/TLR4/MyD88 in the HaCaT cells with no significant effect on the PI3K/Akt signaling pathway. Transfection with AD-p55PIK-GFP increased the protein expression levels of TLR2, TLR4 (to an extent), MyD88 and phosphorylated Akt following LPS stimulation (Fig. 4). These results suggested that the AD-p55PIK-GFP affected the protein expression levels of TLR2/TLR4/MyD88 by upregulating phosphorylated Akt in the HaCaT cells.

Figure 5

Effect of N24 and p55PIK on the expression of the mitogen-activated protein kinase signaling pathway. ERK, extracellular-signal-regulated kinases; JNK, c-Jun N-terminal kinases; p-, phosphorylated; LPS, endotoxin; N24, N-terminal 24 amino acids; P55PIK, p55 regulatory subunit of phosphatidylinositol 3-kinase; AD, adenovirus.

Figure 4

Effect of N24 and p55PIK on the expression levels of the TLRS/MyD88/Akt protein signaling pathway. LPS, endotoxin; TLR, Toll-like receptor; MyD88, myeloid differentiation factor 88; N24, N-terminal 24 amino acids; P55PIK, p55 regulatory subunit of phosphatidylinositol 3-kinase; AD, adenovirus.

Expression of MAPK signaling pathway proteins

The MAPK signaling pathway is important in the LPS-mediated cellular response. In mammalian cells, at least four MAPK subfamilies have been identified, namely the extracellular-signal-regulated kinases (ERK)1/2, c-Jun N-terminal kinases (JNK), p38 and NIMA-associated protein kinase 5. As shown in Fig. 5, the present study demonstrated that the phosphorylation of ERK increased 30 min post-LPS stimulation (P<0.05), peaked at 8 h (P<0.05) and then gradually declined, however, it remained significantly higher compared with the baseline until 24 h (P<0.05). The phosphorylation patterns of JNK and p38 were similar, however, the phosphorylation of p38 decreased rapidly subsequent to peaking at 8 h (P<0.05) and almost returned to basal levels at 24 h. The expression of phosphorylated JNK decreased subsequent to peaking at 4 h (P<0.05) and remained marginally higher compared with basal levels at 24 h (Fig. 5). Transfection with either AD-GFP, AD-N24-GFP or AD-p55PIK-GFP caused no affect on the expression levels of phosphorylated ERK1/2, JNK or p38, suggesting that AD-N24-GFP and AD-p55PIK-GFP had no significant affect on the MAPK signaling pathway.

Discussion

The skin is the body’s first line of defense against outside pathogens and is important in innate immunity. The differentiation features of HaCaT cells and normal human keratinocytes are similar (13) and have been widely used to investigate the activity and functionality of anti-inflammatory drugs (14). TLRs are primarily expressed in immune cells, including dendritic cells, lymphocytes and monocytes/macrophages. In addition, TLRs are expressed in epithelial cells and other non-immune cells (15). TLR signaling consists of at least two distinct pathways: The MyD88-dependent and the MyD88-independent pathways. MyD88 is essential in intracellular signal transduction through TLRs. The C-terminus of MyD88 contains a Toll/interleukin-1 receptor (TIR) domains, which binds to the TIR domain of TLR, IL-1R and IL-18R. The N-terminus contains a death domain (DD), which is responsible for recruiting signaling molecules with DDs, including TNF receptor-associated factor 6 and TAK1 binding protein 1 and 2. This recruitment induces the activation of NF-κB-inducing kinase and the phosphorylation of the NF-kB inhibitor, IκB kinase (IKK1-IKK2-IKKK2). The activation of IKK promotes the ubiquitination and degradation of IκB-α, resulting in the activation of NF-κB, ERK, p38, JNK and other MAPKs, which then activate activator protein 1. Activation of this pathway induces the expression levels of IL-1, IL-6, IL-8, IL-12, TNF-α and other inflammatory cytokines (16).

Phosphoinositide 3-kinases (PI3Ks) are pivotal in inflammatory processes. In vivo and in vitro studies have demonstrated that leukocytes and macrophages lacking PI3Kγ exhibit defective chemotaxis towards various stimuli (17,18). The inhibitory capacity of the selective inhibitor, AS041164, on peritoneal leukocyte chemotaxis towards RANTES is three times higher compared with that of LY294002 (19). LY294002 is a general PI3K inhibitor, whereas AS-041164 is a potent inhibitor of PI3K with selectivity for the class IB isoform PI3Kγ. When administered orally to mice, AS-041164 demonstrates a pharmacokinetic profile that is similar to the general PI3K inhibitor LY294002 but is three times more potent at blocking neutrophil recruitment induced by RANTES. In addition, endothelial PI3K facilitates the adhesion of leukocytes to the inflammatory vessel wall (20). The expression of PI3Kδ in endothelial cells promotes the adhesion of reactive leukocytes and the transmembrane migration of endothelial cells induced by TNF-α and leukotriene B4 (21). These observations demonstrate that PI3Kδ and PI3Kγ are required for the effective recruitment of white blood cells by endothelial cells in response to cytokine stimuli.

The present study established an in vitro model to examine the effects of N24 and p55PIK on the expression levels of TLR signaling pathway proteins in LPS-stimulated HaCaT cells. The NF-κB p65 protein translocation into the nucleus was altered upon LPS stimulation and N24 significantly suppressed this translocation. Furthermore, the ubiquitination and subsequent degradation of NF-κB p65 was observed in LPS-stimulated HaCaT cells. N24, but not p55PIK, significantly inhibited this ubiquitination and degradation, suggesting that N24 can effectively inhibit NF-κB p65 translocation into the nucleus and prevent the release of pro-inflammatory cytokines. The expression levels of TLR2, TLR4 and MyD88 were demonstrated to increase with prolonged LPS stimulation in the HaCaT cells. The expression of N24 caused a reduction in the expression levels of TLR2, TLR4 and Myd88 in response to LPS stimulation. By contrast, p55PIK promoted the expression levels of TLR2, TLR4 and MyD88, suggesting that activation of PI3K increased the immune response to LPS, while N24 functioned as a PI3K inhibitor. The effects of N24 and p55PIK on the MAPK pathway, another TLR-mediated inflammatory signaling pathway, were also investigated. N24 and p55PIK caused no significant change to the phosphorylation of ERK1/2, JNK or p38, suggesting that N24 and p55PIK affect TLRs/MyD88-mediated signaling in an MAPK-independent manner.

In conclusion, the present study demonstrated the effect of N24 and p55PIK on TLR signaling and the suitability of PI3K as a potential novel target for immunosuppressant therapy and N24 as a novel candidate immunosuppressant. The underlying mechanism of N24 was also examined. These findings provide a theoretical basis for the identifcation of immunosuppressive drugs and therapeutic strategies against AID.

Acknowledgements

This study was supported by a grant from the National Science Foundation of China (no. 81072431).

References

1 

Cho JH and Gregersen PK: Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med. 365:1612–1623. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Bogdanos DP, Smyk DS, Rigopoulou EI, et al: Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun. 38:J156–J169. 2012. View Article : Google Scholar

3 

Bruce B1 and Fries JF: The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol. 30:167–178. 2003.PubMed/NCBI

4 

Bos JD and De Rie MA: The pathogenesis of psoriasis: Immunological facts and speculations. Immunol Today. 20:40–46. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Lowes MA, Kikuchi T, Fuentes-Duculan J, et al: Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 128:1207–1211. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Sauder DN, Voorhees JJ and Fisher G: IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol. 144:4593–4603. 1990.PubMed/NCBI

7 

Gomi T, Shiohara T, Munakata T, Imanishi K and Nagashima M: Interleukin 1 alpha, tumor necrosis factor alpha and interferon gamma in psoriasis. Arch Dermatol. 127:827–830. 1991. View Article : Google Scholar : PubMed/NCBI

8 

Neuner P, Urbanski A, Trautinger F, Moller A, Kirnbauer R, Kapp A, Schopf E, Schwarz T and Luger TA: Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol. 97:27–33. 1991. View Article : Google Scholar : PubMed/NCBI

9 

Luger TA and Schwarz T: Evidence for an epidermal cytokine network. J Invest Dermatol. 95:100S–104S. 1990. View Article : Google Scholar : PubMed/NCBI

10 

Gilhar A, Pillar T and Etzioni A: Possible role of cytokines in cellular proliferation of the skin transplanted onto nude mice. Arch Dermatol. 131:38–42. 1995. View Article : Google Scholar : PubMed/NCBI

11 

Stein M, Bernd A, Ramirez-Bosca A, Kippenberger S and Holzmann H: Measurement of anti-inflammatory effects of glucocorticoids on human keratinocytes in vitro. Comparison of normal human keratinocytes with the keratinocyte cell line HaCaT. Arzneimittelforschung. 47:1266–1270. 1997.

12 

Hu J, Xia X, Cheng A, Wang G, Luo X, Reed MF, Fojo T, Oetting A, Gong J and Yen PM: A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Mol Cancer Ther. 7:3719–3728. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Mutis T, De Bueger M, Bakker A and Ottenhoff TH: HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells. Scand J Immunol. 37:43–51. 1993. View Article : Google Scholar : PubMed/NCBI

14 

Barker JN, Mitra RS, Griffiths CE, Dixit VM and Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet. 337:211–214. 1991. View Article : Google Scholar : PubMed/NCBI

15 

Akira S: Toll-like receptors and innate immunity. Adv Immunol. 78:1–56. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Su SB, Silver PB, Grajewski RS, Agarwal RK, Tang J, Chan CC and Caspi RR: Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol. 175:6303–6310. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, et al: Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science. 297:1031–1034. 2002.PubMed/NCBI

18 

Iwasaki A and Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol. 5:987–995. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV and Wu D: Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science. 287:1046–1049. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Puri KD, Doggett TA, Huang CY, Douangpanya J, Hayflick JS, Turner M, Penninger J and Diacovo TG: The role of endothelial PI3Kgamma activity in neutrophil trafficking. Blood. 106:150–157. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Puri KD, Doggett TA, Douangpanya J, Hou Y, Tino WT, Wilson T, Graf T, Clayton E, Turner M, Hayflick JS, et al: Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood. 103:3448–3456. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lv F, Yu Y, Wang G, Hu J, Zhang B, You W and Wang J: Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes. Mol Med Rep 11: 3753-3759, 2015.
APA
Lv, F., Yu, Y., Wang, G., Hu, J., Zhang, B., You, W., & Wang, J. (2015). Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes. Molecular Medicine Reports, 11, 3753-3759. https://doi.org/10.3892/mmr.2015.3184
MLA
Lv, F., Yu, Y., Wang, G., Hu, J., Zhang, B., You, W., Wang, J."Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes". Molecular Medicine Reports 11.5 (2015): 3753-3759.
Chicago
Lv, F., Yu, Y., Wang, G., Hu, J., Zhang, B., You, W., Wang, J."Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes". Molecular Medicine Reports 11, no. 5 (2015): 3753-3759. https://doi.org/10.3892/mmr.2015.3184
Copy and paste a formatted citation
x
Spandidos Publications style
Lv F, Yu Y, Wang G, Hu J, Zhang B, You W and Wang J: Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes. Mol Med Rep 11: 3753-3759, 2015.
APA
Lv, F., Yu, Y., Wang, G., Hu, J., Zhang, B., You, W., & Wang, J. (2015). Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes. Molecular Medicine Reports, 11, 3753-3759. https://doi.org/10.3892/mmr.2015.3184
MLA
Lv, F., Yu, Y., Wang, G., Hu, J., Zhang, B., You, W., Wang, J."Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes". Molecular Medicine Reports 11.5 (2015): 3753-3759.
Chicago
Lv, F., Yu, Y., Wang, G., Hu, J., Zhang, B., You, W., Wang, J."Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes". Molecular Medicine Reports 11, no. 5 (2015): 3753-3759. https://doi.org/10.3892/mmr.2015.3184
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team